Health Care: Drugs

Sanofi (SNY: NYSE)

$54.86 0.30 | 0.55%
05/24/13 - 04:02 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 47.55B 45.44B 42.98B 44.06B
Cost of Sales 12.57B 11.23B 10.13B 9.17B
Gross Operating Profit 34.99B 34.21B 32.85B 34.89B
Selling, General, and Administrative Expenses 12.43B 11.47B 10.52B 11.18B
Research & Development 6.51B 6.24B 5.90B 6.57B
Operating Income before D & A (EBITDA) 16.04B 16.50B 16.42B 17.14B
Depreciation & Amortization 6.49B 7.20B 6.88B 7.18B
Interest Income 122.99M 181.45M 140.86M 34.39M
Other Income - Net 1.26B 1.40B 1.61B 2.41B
Special Income / Charges -408.65M -184.05M 0.00 -532.98M
Total Income Before Interest Expenses (EBIT) 9.02B 9.00B 9.45B 10.32B
Interest Expense 731.35M 715.44M 626.50M 464.21M
Pre-Tax Income 8.29B 8.28B 8.82B 9.86B
Income Taxes 1.50B 589.72M 1.67B 1.95B
Minority Interest 223.50M 312.36M 340.75M 610.35M
Net Income From Continuing Operations 6.79B 0.00 7.16B 7.90B
Net Income From Discontinued Operations 0.00 0.00 517.84M 250.73M
Net Income From Total Operations 6.79B 0.00 7.67B 8.15B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 6.57B 7.38B 7.33B 7.54B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 8.71B 1.89B 9.00B 9.98B
Preferred Dividends
Net Income Available To Common 6.79B 0.00 7.16B 7.90B
Basic EPS from Continuing Ops. 2.49 2.79 2.81 2.89
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.49 2.79 2.81 2.89
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.49 2.79 2.81 2.89
Basic Normalized Net Income/Share 3.19 n.a. 3.53 3.65
EPS fr Continuing Ops. 2.47 2.78 2.80 2.89
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.47 2.78 2.80 2.89
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.47 2.78 2.80 2.89
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 3.17 n.a. 3.52 3.65
Dividends Paid per Share 1.69 1.32 1.10 1.44

Portfolios with SNY

View All

Latest SNY Headlines from TheStreet

More Financial News for SNY

Press Releases for SNY

See All Press Releases

Partner Headlines for SNY

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter